Reckitt Benckiser has issued a voluntary recall for Mead Johnson Nutrition brand's baby formula powder. The U.S. Food and Drug Administration (US FDA) said that the health and nutrition firm decided to recall some batches of the said product due to possible bacterial contamination.
As per CNBC, the affected infant formula is being sold in the market as Nutramigen Powder. This infant formula is specially made for babies allergic to cow's milk. The recalled batches were produced in June and distributed to stores in the summer.
Recalled Batches of Nutramigen Powder
Reckitt Benckiser said that so far, it has not received any reports of illnesses or adverse effects related to the recalled Nutramigen Powder. However, the company is urging customers who have bought the milk formula to check the can to see if what they purchased is included in the batches that may have been contaminated.
The company said that the affected products have these batch numbers and their corresponding can sizes: ZL3FHG, 12.6 oz cans, ZL3FMH, 12.6 oz cans, ZL3FPE, 12.6 oz cans, ZL3FQD, 12.6 oz cans, ZL3FRW, 19.8 oz cans, and ZL3FXJ, 12.6 oz cans.
Adverse Effects of Bacterial Infection
Fox Business says the total number of the affected Nutramigen infant powder is about 675,030 cans. The FDA warned on Sunday, Dec. 31, that they may be contaminated with Cronobacter sakazakii.
The National Food Administration further said that the milk formula was made at a production facility in Michigan. The bacteria in the product potentially cause severe infections such as meningitis and sepsis. The FDA listed jaundice, irritability, temperature change, poor feeding, trouble breathing, and unusual movements as the common symptoms of the infection.
Meanwhile, the announcement stressed, "No other U.S. distributed Nutramigen batches or other Reckitt products are impacted."
Photo by: Reckltt Press Release


United Airlines Flight to Tokyo Returns to Dulles After Engine Failure During Takeoff
Azul Airlines Wins Court Approval for $2 Billion Debt Restructuring and New Capital Raise
Mizuho Raises Broadcom Price Target to $450 on Surging AI Chip Demand
Rio Tinto Signs Interim Agreement With Yinhawangka Aboriginal Group Over Pilbara Mining Operations
SoftBank Shares Slide as Oracle’s AI Spending Plans Fuel Market Jitters
ANZ Faces Legal Battle as Former CEO Shayne Elliott Sues Over A$13.5 Million Bonus Dispute
Coca-Cola’s Proposed Sale of Costa Coffee Faces Uncertainty Amid Price Dispute
JD.com Pledges 22 Billion Yuan Housing Support for Couriers as China’s Instant Retail Competition Heats Up
Trello Outage Disrupts Users as Access Issues Hit Atlassian’s Work Management Platform
Korea Zinc Plans $6.78 Billion U.S. Smelter Investment With Government Partnership
Evercore Reaffirms Alphabet’s Search Dominance as AI Competition Intensifies
SpaceX Begins IPO Preparations as Wall Street Banks Line Up for Advisory Roles
Fortescue Expands Copper Portfolio With Full Takeover of Alta Copper
Air Force One Delivery Delayed to 2028 as Boeing Faces Rising Costs
Coca-Cola’s Costa Coffee Sale Faces Uncertainty as Talks With TDR Capital Hit Snag
Apple App Store Injunction Largely Upheld as Appeals Court Rules on Epic Games Case
California Jury Awards $40 Million in Johnson & Johnson Talc Cancer Lawsuit 



